PMID: 8607729Feb 26, 1996Paper

Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated

Archives of Internal Medicine
S E VartivarianE J Anaissie

Abstract

Stenotrophomonas (Xanthomonas) maltophilia has emerged as a causative agent of serious nosocomial infections. However, well-documented cases of urinary tract infection with this organism have rarely been reported. review of the medical records of patients admitted to a large cancer center with cultures yielding S maltophilia from urinary sources during a 15-month period. All urinary tract infections were serious: 13 were complicated and two were acute uncomplicated pyelonephritis. The urinary tracts of 13 other patients were colonized with S maltophilia. Most of the colonized and infected patients were hospitalized with genitourinary malignancy, underwent urinary catheterization, and were receiving antibiotics inactive against S maltophilia. Neutropenia and urinary structural abnormalities were significantly associated with infection. The clinical course of infection was usually severe: fever (100%), sepsis disorder (47%), neutrophilia (70% of patients without neutropenia), bacteremia (13%) and death (7%). Still, response to treatment was prompt. Stenotrophomonas maltophilia urinary tract infection is usually associated with a severe clinical course. Risk factors for urinary colonization by this organism include hospitalization...Continue Reading

Citations

Apr 19, 2007·Archives of Microbiology·Chiy-Rong ChenShu-Fen Weng
Jan 4, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G AisenbergA Safdar
Mar 6, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A C Nicodemo, J I Garcia Paez
Feb 19, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M E FalagasG Dimopoulos
Oct 15, 2003·Burns : Journal of the International Society for Burn Injuries·Maria DalamagaIlias Migdalis
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A SattlerS L Kaplan
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Anna RiberaJordi Vila
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·María Dolores Navarro-MartínezJosé Neptuno Rodríguez-López
Mar 5, 2005·Applied and Environmental Microbiology·Hsiao-Chuan ChangShu-Fen Weng
Jan 11, 2012·Clinical Microbiology Reviews·Joanna S Brooke
Aug 9, 2003·Journal of Clinical Microbiology·Chiranjoy MukhopadhyayArchana Ayyagari
Oct 9, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ya-Ting ChangYen-Hsu Chen
Apr 13, 2012·The Journal of Hospital Infection·M GaraziC C Ginocchio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
F Gutiérrez RoderoA Vilar
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Chia-Cheng TsengMeng-Chih Lin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
K A PapadakisE J Anaissie
© 2021 Meta ULC. All rights reserved